Novel protocol for persister cells isolation

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Cañas Duarte, Silvia J ^a   Restrepo, Silvia ^a   Pedraza, Juan Manuel ^a  

^a UNIVERSIDAD DE LOS ANDES   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; OFLOXACIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELLULAR STRESS RESPONSE; CLINICAL PROTOCOL; ESCHERICHIA COLI; NONHUMAN; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIAL VIABILITY; PHYSIOLOGY; SPECIES DIFFERENCE; TIME LAPSE IMAGING;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; MICROBIAL VIABILITY; SPECIES SPECIFICITY; TIME-LAPSE IMAGING;

EID: 84896131203     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088660     Document Type: Article

References (26)

1. Dörr T, Lewis K, Vulić M (2009) SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet 5: e1000760. doi:10.1371/journal.pgen.1000760.
2. Gefen O, Balaban NQ (2009) The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress. FEMS Microbiol Rev 33: 704-717. doi:10.1111/j.1574-6976.2008.00156.x.
3. Lewis K (2010) Persister cells. Annu Rev Microbiol 64: 357-372. doi:10.1146/annurev.micro.112408.134306.
4. Korch SB, Henderson TA, Hill TM (2003) Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesi s. Mol Microbiol 50: 1199-1213. doi:10.1046/j.1365-2958.2003. 03779.x. (Pubitemid 37475853)
5. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S (2004) Bacterial persistence as a phenotypic switch. Science 305: 1622-1625. doi:10.1126/science. 1099390. (Pubitemid 39296357)
6. Kint C, Verstraeten N, Fauvart M, Michiels J (2012) New-found fundamentals of bacterial persistence. Trends Microbiol 20: 577-585. doi:10.1016/j.tim.2012.08.009.
7. Bigger J (1944) TREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH PENICILLIN BY INTERMITTENT STERILISATION. Lancet 244: 497-500. doi:10.1016/S0140-6736(00) 74210-3.
8. Moyed HS, Broderick SH (1986) Molecular cloning and expression of hipA, a gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 166: 399-403. (Pubitemid 16112134)
9. Wolfson JS, Hooper DC, McHugh GL, Bozza M a, Swartz MN (1990) Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone and betalactam antimicrobial agents. Antimicrob Agents Chemother 34: 1938-1943. (Pubitemid 20290293)
10. Spoering AL, Lewis K (2001) Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol 183: 6746-6751. doi:10.1128/JB.183.23.6746-6751.2001. (Pubitemid 33064186)
11. Dhar N, McKinney JDJ (2007) Microbial phenotypic heterogeneity and antibiotic tolerance. Curr Opin Microbiol 10: 30-38. doi:10.1016/j.mib.2006.12. 007. (Pubitemid 46216877)
12. Keren I, Minami S, Rubin E, Lewis K (2011) Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. MBio 2: e00100-11. doi:10.1128/mBio.00100-11.
13. Lewis K (2001) Riddle of biofilm resistance. Antimicrob Agents Chemother 45. doi:10.1128/AAC.45.4.999.
14. Kussell E, Kishony R, Balaban NQ, Leibler S (2005) Bacterial persistence: a model of survival in changing environments. Genetics 169: 1807-1814. doi:10.1534/genetics.104.035352. (Pubitemid 40695598)
15. Hong S, Wang X (2012) Bacterial persistence increases as environmental fitness decreases. Microb ... 5: 509-522. doi:10.1111/j.1751-7915.2011.00327.x.
16. Maisonneuve E (2011) Bacterial persistence by RNA endonucleases. Proc .... doi:10.1073/pnas.1100186108/-/DCSupplemental.www.pnas.org/cgi/doi/10.1073/ pnas.1100186108.
17. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K (2004) Specialized Persister Cells and the Mechanism of Multidrug Tolerance in Escherichia coli. J ... 186: 8172-8180. doi:10.1128/JB.186.24.8172.
18. Shah D, Zhang Z, Khodursky A, Kaldalu N, Kurg K, et al. (2006) Persisters: a distinct physiological state of E. coli. BMC Microbiol 6: 53. doi:10.1186/1471-2180-6-53.
19. Maisonneuve E, Castro-Camargo M, Gerdes K (2013) (p)ppGpp controls bacterial persistence by stochastic induction of toxin-antitoxin activity. Cell 154: 1140-1150. doi:10.1016/j.cell.2013.07.048.
20. Moyed HS, Bertrand KP (1983) hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 155: 768-775. (Pubitemid 13048115)
21. Dörr T, Vulić M, Lewis K (2010) Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol 8: e1000317. doi:10.1371/journal.pbio.1000317.
22. Gradelski E, Kolek B, Bonner D, Fung-Tomc J (2002) Bactericidal mechanism of gatifloxacin compared with other quinolones. J Antimicrob Chemother 49: 185-188. (Pubitemid 34100665)
23. Fux CA, Wilson S, Stoodley P (2004) Detachment characteristics and oxacillin resistance of Staphyloccocus aureus biofilm emboli in an in vitro catheter infection model. J Bacteriol 186: 4486-4491. doi:10.1128/JB.186.14. 4486-4491.2004. (Pubitemid 38891011)
24. Herbert D, Paramasivan CN, Venkatesan P, Kubendiran G, Prabhakar R, et al. (1996) Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis. Antimicrob Agents Chemother 40: 2296-2299. (Pubitemid 26328035)
25. Michel J-B, Yeh PJ, Chait R, Moellering RC, Kishony R (2008) Drug interactions modulate the potential for evolution of resistance. Proc Natl Acad Sci U S A 105: 14918-14923. doi:10.1073/pnas.0800944105.
26. Korch SB, Hill TM (2006) Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J Bacteriol 188: 3826-3836. doi:10.1128/JB.01740-05. (Pubitemid 43825388)